Between December 2024 and February 2025, ten newborns with hypoxic-ischemic brain injury were treated with breast milk administered through the nasal passages using a special method at Semmelweis University in Budapest. A study on this novel and promising therapeutic approach was recently published in Pediatric Research, one of the most prestigious scientific journals under the Nature portfolio. The procedure is expected to help mitigate the consequences of brain damage caused by oxygen deprivation, and breast milk delivered intranasally may become a safe therapeutic tool for long-term use even in controlled home environments.

Breast cancer remains a leading cause of malignancy-related mortality among women globally, with triple-negative breast cancer (TNBC) posing a significant clinical challenge due to its aggressive nature and early metastatic potential. Previous studies have implicated obesity in driving tumor progression, often associating it with diminished therapeutic responses and poor survival outcomes.

Gallbladder cancer (GBC) is the most common malignancy of the biliary system, often presenting with an abysmal prognosis due to its high propensity for early lymph node metastasis. While previous research has linked the reactivation of the highly conserved translation elongation factor eEF1A2 to poor outcomes in various cancers, its exact functional mechanisms driving GBC metastasis have remained elusive.

Cancer cells survive by repairing damage to their DNA—even damage that would normally be fatal. One of their most important defense systems is homologous recombination, a high-precision repair pathway that fixes broken DNA using key proteins such as RAD51 and CHK1. While therapies such as PARP inhibitors have successfully targeted this vulnerability, many tumors eventually regain their DNA repair ability and become resistant to treatment.

A research team led by Director MYUNG Kyungjae at the Center for Genomic Integrity within the Institute for Basic Science (IBS), in collaboration with LEE Joo-Yong (Chungnam University) has now uncovered a new strategy to overcome this resistance. Their findings show that cancer cells can be made vulnerable again—not by altering genetic mutations, but by destabilizing the DNA repair machinery itself.

The University of Texas MD Anderson Cancer Center today announced the appointment of Kim Slusser, Ph.D., R.N., as the institution’s inaugural chief nurse executive (CNE), effective May 1.

Tiny flexible lasers can be used to measure forces inside living cells, which could help illuminate various biological processes, including those involved in early development and tumor progression.